Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CYDY US Equity

CytoDyn Inc.Health Care · Pharmaceutical Preparations · CIK 1175680 · FY ends May 31
$0.21
+0.01 (+4.04%)
USD · as of 2026-08-20 · marketstack

Legal & controls

5 of 5 annual reports readable here

Item 3 and Item 9A as filed · every verdict is the registrant’s own sentence, printed below it · a filing that fails an extraction gate reads “not extracted”

Fiscal yearFiledItem 3ICFRdisclosure controlsmaterial weaknessFiling
2025-05-312025-07-25in the noteseffectivenot extractednone in Item 9AEDGAR

Item 3 · For a description of material legal proceedings, refer to Part II, Item 8, Note 9, Commitments and Contingencies – Legal Proceedings in this Form 10-K.

Item 9A · ICFR · Based on this evaluation, our management concluded that our internal control over financial reporting was effective as of May 31, 2025.

2024-05-312024-08-15in the noteseffectivenot extractednone in Item 9AEDGAR

Item 3 · For a description of material legal proceedings, refer to Part II, Item 8, Note 10, Commitments and Contingencies in this Form 10-K.

Item 9A · ICFR · Based on this evaluation, our management concluded that our internal control over financial reporting was effective as of May 31, 2024.

2023-05-312023-09-14in the noteseffectivenot extractedremediated (prior year)EDGAR

Item 3 · For a description of material legal proceedings, refer to Part II, Item 8, Note 10, Commitments and Contingencies in this Form 10-K.

Item 9A · ICFR · Based on this evaluation, our management concluded that our internal control over financial reporting was effective as of May 31, 2023.

Item 9A · material weakness · The remediation steps described below were designed to address the material weaknesses previously identified by management and strengthen our internal control over financial reporting.

2022-05-312022-08-15in the notesNOT effectivenot extractedremediated (prior year)EDGAR

Item 3 · For a description of material legal proceedings, refer to Part II, Item 8, Note 10, Commitments and Contingencies of this Form 10-K.

Item 9A · ICFR · Based on this evaluation, our management concluded that our internal control over financial reporting were not effective as of May 31, 2022.

Item 9A · material weakness · In connection with the identification of the material weaknesses in our internal control over financial reporting, we continue to evaluate, design and implement controls and procedures to address this weakness.

2021-05-312021-07-30in the noteseffectivenot extractednone in Item 9AEDGAR

Item 3 · For a description of any pending material legal proceedings, please see Note 10. Commitments and Contingencies of the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Form 10-K.

Item 9A · ICFR · Based on this evaluation, our management concluded that our internal control over financial reporting was effective as of May 31, 2021.

5 of 5 annual reports on record have their filing text cached on this host; the rest are listed with their EDGAR link and no extraction, because this surface never fetches from SEC on a page load.

  • Item 3 and Item 9A are located in the filing HTML already cached on this host and read with the same line-anchored item matcher and largest-gap body disambiguation the filing-narrative pass uses for Item 1A and Item 7 — no fetch, no model, no summarization.
  • A heading is accepted as a section only when it is not a table-of-contents row (a trailing page number), not a quoted reference in prose, and names its own section; the span must then clear a per-item length band and carry readable text after the heading. Anything that fails a gate is served as 'not extracted' with the reason — never as a default value.
  • An effectiveness conclusion is read only from a sentence that names its own control set (disclosure controls and procedures, or internal control over financial reporting) and states an outcome. Conditional sentences — the standard limitations paragraph and forward-looking remediation language — are excluded, because they are hypotheses rather than conclusions.
  • When a filing's own sentences disagree — an effective conclusion beside an unremediated material-weakness disclosure, or two conclusions of opposite sign — no verdict is asserted. A wrong 'controls were effective' reading is worse than no reading.
  • Every verdict is shown beside the verbatim sentence it was read from. The excerpt is the filing's own words, capped at 1,200 characters; the filing itself is one link away.